Announcement on Convening Performance Briefing for 2025 and Q1 2026
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Convening Performance Briefing for 2025 and Q1 2026
Filed with SSE · · 3 pages · Chinese
Release
Wuhan Healthgen Biotechnology Corp on 6ix
Earlier from Wuhan Healthgen Biotechnology
- On-site Inspection Report on Continuous Supervision of WUHAN HEALTHGEN BIOTECHNOLOGY CORP. by GUOTAI HAITONG SECURITIES CO., LTD. in 2025
- Notice on Convening the 2025 Annual General Meeting
- Announcement on Circulation of Restricted Stocks in Offline Placement of Initial Public Offering
- Announcement on Preliminary Earnings Estimate for 2025
- Earnings Preannouncement for 2025
Later from Wuhan Healthgen Biotechnology
- Semi-annual Tracking Report on Continuous Supervision of WUHAN HEALTHGEN BIOTECHNOLOGY CORP. in 2025
- Announcement on Pledge of Partial Shares by Shareholders with Over 5% of Shares
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Completing Industrial and Commercial Change Registration and Obtaining Renewed Business License
- Announcement on Wholly-owned Subsidiary Opening Special Account for Raised Funds and Signing Supervision Agreement
Follow Wuhan Healthgen Biotechnology into a list and get an email when it puts out news.
Follow Wuhan Healthgen Biotechnology